These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 12925557)

  • 41. Blood pressure reduction and risk of dementia in patients with stroke: rationale of the dementia assessment in PROGRESS (Perindopril Protection Against Recurrent Stroke Study). PROGRESS Management Committee.
    Tzourio C; Anderson C;
    J Hypertens Suppl; 2000 May; 18(1):S21-4. PubMed ID: 10939786
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Effect of ACE gene polymorphism on carbohydrate metabolism, on oxidative stress and on end-organ damage in type-2 diabetes mellitus].
    Molnár GA; Wagner Z; Wagner L; Melegh B; Kószegi T; Degrell P; Bene J; Tamaskó M; Laczy B; Nagy J; Wittmann I
    Orv Hetil; 2004 Apr; 145(16):855-9. PubMed ID: 15156690
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Lack of association between angiotensin converting enzyme gene insertion/deletion polymorphism and stroke.
    Ueda S; Weir CJ; Inglis GC; Murray GD; Muir KW; Lees KR
    J Hypertens; 1995 Dec; 13(12 Pt 2):1597-601. PubMed ID: 8903617
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ischemic stroke and the gene for angiotensin-converting enzyme in Japanese hypertensives.
    Kario K; Kanai N; Saito K; Nago N; Matsuo T; Shimada K
    Circulation; 1996 May; 93(9):1630-3. PubMed ID: 8653866
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Perindopril pROtection aGainst REcurrent Stroke Study (PROGRESS): interpretation and implementation.
    Chalmers J; MacMahon S
    J Hypertens Suppl; 2003 Jun; 21(5):S9-14. PubMed ID: 12953850
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting response to chronic antihypertensive treatment with fosinopril: the role of angiotensin-converting enzyme gene polymorphism.
    Stavroulakis GA; Makris TK; Krespi PG; Hatzizacharias AN; Gialeraki AE; Anastasiadis G; Triposkiadis P; Kyriakidis M
    Cardiovasc Drugs Ther; 2000 Aug; 14(4):427-32. PubMed ID: 10999650
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Ongoing trials of angiotensin-converting enzyme inhibition: what they can tell us.
    Chalmers JP
    Am J Hypertens; 2001 Aug; 14(8 Pt 2):270S-275S. PubMed ID: 11497208
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Perindopril-based blood pressure lowering in individuals with cerebrovascular disease: consistency of benefits by age, sex and region.
    Rodgers A; Chapman N; Woodward M; Liu LS; Colman S; Lee A; Chalmers J; MacMahon S;
    J Hypertens; 2004 Mar; 22(3):653-9. PubMed ID: 15076173
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Modulation of the renal response to ACE inhibition by ACE insertion/deletion polymorphism during hyperglycemia in normotensive, normoalbuminuric type 1 diabetic patients.
    Weekers L; Bouhanick B; Hadjadj S; Gallois Y; Roussel R; Pean F; Ankotche A; Chatellier G; Alhenc-Gelas F; Lefebvre PJ; Marre M
    Diabetes; 2005 Oct; 54(10):2961-7. PubMed ID: 16186399
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Trials on blood pressure-lowering and secondary stroke prevention.
    Chalmers J
    Am J Cardiol; 2003 May; 91(10A):3G-8G. PubMed ID: 12781902
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Randomized placebo-controlled trial of perindopril in normotensive, normoalbuminuric patients with type 1 diabetes mellitus.
    Kvetny J; Gregersen G; Pedersen RS
    QJM; 2001 Feb; 94(2):89-94. PubMed ID: 11181984
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effects of a perindopril-based blood pressure lowering regimen on cardiac outcomes among patients with cerebrovascular disease.
    PROGRESS Collaborative Group
    Eur Heart J; 2003 Mar; 24(5):475-84. PubMed ID: 12633548
    [TBL] [Abstract][Full Text] [Related]  

  • 53. What is the impact of the ACE gene insertion/deletion (I/D) polymorphism on the clinical effectiveness and adverse events of ACE inhibitors?--Protocol of a systematic review.
    Scharplatz M; Puhan MA; Steurer J; Bachmann LM
    BMC Med Genet; 2004 Sep; 5():23. PubMed ID: 15361261
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Blood pressure lowering for the secondary prevention of stroke: rationale and design for PROGRESS.
    PROGRESS Management Committee
    J Hypertens Suppl; 1996 Sep; 14(2):S41-5; discussion S45-6. PubMed ID: 8934377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Effect of Angiotensin-Converting Enzyme Gene Polymorphisms on the Clinical Efficacy of Perindopril Prescribed for Acute Myocardial Infarction in Chinese Han Patients.
    Lin P; Li H; Yu T; Liu Y
    Genet Test Mol Biomarkers; 2019 May; 23(5):316-324. PubMed ID: 30942616
    [No Abstract]   [Full Text] [Related]  

  • 56. Angiotensin-converting enzyme activity and inhibition in dogs with cardiac disease and an angiotensin-converting enzyme polymorphism.
    Meurs KM; Stern JA; Atkins CE; Adin D; Aona B; Condit J; DeFrancesco T; Reina-Doreste Y; Keene BW; Tou S; Ward J; Woodruff K
    J Renin Angiotensin Aldosterone Syst; 2017; 18(4):1470320317737184. PubMed ID: 29069972
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Deletion polymorphism in the angiotensin-converting enzyme gene in patients with a history of ischemic stroke.
    Margaglione M; Celentano E; Grandone E; Vecchione G; Cappucci G; Giuliani N; Colaizzo D; Panico S; Mancini FP; Di Minno G
    Arterioscler Thromb Vasc Biol; 1996 Feb; 16(2):304-9. PubMed ID: 8620347
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time to consider ACE insertion/deletion genotypes and individual renoprotective treatment in diabetic nephropathy?
    Jacobsen PK; Tarnow L; Parving HH
    Kidney Int; 2006 Apr; 69(8):1293-5. PubMed ID: 16612410
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Angiotensin-converting enzyme inhibitor use is associated with reduced plasma concentration of C-reactive protein in patients with first-ever ischemic stroke.
    Di Napoli M; Papa F
    Stroke; 2003 Dec; 34(12):2922-9. PubMed ID: 14605324
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prior events predict cerebrovascular and coronary outcomes in the PROGRESS trial.
    Arima H; Tzourio C; Butcher K; Anderson C; Bousser MG; Lees KR; Reid JL; Omae T; Woodward M; MacMahon S; Chalmers J;
    Stroke; 2006 Jun; 37(6):1497-502. PubMed ID: 16627794
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.